News
Starting July 1, CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor Novo Nordisk, will still be covered under plans managed by ...
GLP-1s (glucagon-like peptide-1 receptor agonists), like Wegovy, Ozempic, or generic liraglutide, have helped you reach your ...
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
The Trump administration is planning an experiment to cover weight-loss drugs under Medicare and Medicaid, the Washington ...
GLP-1 weight loss medications like Ozempic and Wegovy could increase testosterone levels and help prevent erectile ...
TAMPA, FL / ACCESS Newswire / July 29, 2025 / The explosive popularity of GLP-1 weight-loss medications such as Ozempic®, ...
In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who ...
Long Islanders suffering from sleep apnea inundated the sleep center at St. Charles Hospital in Port Jefferson with phone ...
Weight-inclusive health care is the provision of equitable care without perpetuating weight stigma among patients of all body shapes and sizes.
Some obese Americans on Medicare and Medicaid could get access to expensive weight loss drugs under a five-year experiment ...
GLP-1 medications like semaglutide and tirzepatide are helping people shed weight and keep it off. But let’s be clear: These aren’t miracle pills you buy off ...
A day or so after the 30-year-old middle school English teacher and mother took her first injection of compounded tirzepatide, Smith had plans to go to Olive Garden with her coworkers. Smith ordered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results